research

1. The characteristics of personality disorders are: mental disease. It contains symptoms that are enduring and play a key role in most, if not all, aspects of the persons life. While many disorders think twice in terms of symptom presence and intensity, personality disorders typically remain relatively constant.

2. Personality disorders are associated with genetic factors. Experiences of distress or fear during childhood, such as neglect or abuse, are common. Personality disorders typically emerge in adolescence and continue into adulthood. It may be mild, moderate or severe, and people may have periods of remission where they function well. Individuals with borderline personality disorder (BPD) frequently suffer from other psychiatric disorders as well. When this occurs, they have a “co-occurring” or “comorbid” disorder. The reason borderlines are vulnerable to co-occurring disorders may be partially due to their particular genetic makeup

3. The most common symptoms are:
-Intense emotions and mood swings.
-Harmful, impulsive behaviors.
-Relationship problems.
-You being fell alone.
-Aggressive behavior.

4. Psychotherapy is always or nearly always the treatment uses for the disorder; the medication is used to stabilize the mood swings.  Also the other treatment for the personality disorder is antipsychotic pills.

5. The antipsychotics medication can be effective in reducing some of the symptoms of BPD, also persons 

with this medication reduce the anxiety and paranoid thinking.

6. An antipsychotic is firstly used to manage psychosis but also is using to BPD.

7. The total average daily cost of the antipsychotic was higher for $15.33.

8.  In Chile is not very expensive the antipsychotic. Borderline personality disorder can be treated with psychotherapy, professional in some cases recommend medications to treat specific symptoms. No medications have been approved by the U.S. to treat borderline personality disorder.

9. 100 cases of multiple personality disorder (MPD), a dissociative condition that has been poorly characterized, were collected through a 386-item questionnaire completed by clinicians involved in the treatment of MPD patients.